Grow Opportunities
Grow Biotech
Grow Yourself
Save the date: 22-23 April 2026
3rd Global Biologics India
Le Meridien, Hyderabad
22-23 April 2026
Note: Conference will start both days at 9AM
Check in will be open from 8AM
Breakfast would be served from 7 to 9AM
Program Agenda - Modules, Key Topics and Panel Discussion
We will have two tracks on both days: One for Cell and Gene Therapy and other track on Mabs.
Biologics: General Topics
Topic 1: Trends in Biotechnology
Topic 2: AI in Biotech- Endless opportunities
Topic 3: Regulatory and GMP Compliance
Topic 4: Facilities: How India can meet the world’s demand?
Topic 5: Raw Materials: Supply chain and the cost
TRACK 1
Cell and Gene Therapy
Details coming soon...
Panel Discussion 1: Cell and Gene Therapy- Progress, Challenges, and Future Outlook
Panel Discussion 2: Cell and Gene Therapy- New Technologies- CAR T, CRISPR and next….
Panel Members: Coming Soon
Moderator: Coming soon
Module CGT 1: Cell Therapy: Challenges and Solutions
Topic 1
Topic 2
Topic 3
Module CGT 2: NK Cells: Practical Solutions
Topic 1
Topic 2
Topic 3
Module CGT 3: CGT: BioManufacturing, Automation at Scale and Bioreactors
Topic 1
Topic 2
Topic 3
Module CGT 4: Stem Cells: Applications and Future Directions
Topic 1
Topic 2
Topic 3
Module CGT 5: Down-Stream purification and GMP Compliance for Cell Therapy products
Topic 1
Topic 2
Topic 3
Module CGT 6 AAV- High Productivity and Robustness
Topic 1
Topic 2
Topic 3
Module CGT 7: Next Generation Cell Therapy products
Topic 1
Topic 2
Topic 3
Module CGT 8: AI in CGT: How and what?
Topic 1
Topic 2
Topic 3
Module CGT 9: CAR T cells: Process and Next Generation of therapies
Topic 1
Topic 2
Topic 3
Module CGT 10: CGT: Regulatory and GMP Compliance
Topic 1
Module CGT 11: CRISPR/New Technologies
Topic 1
Module CGT 12: Process Characterization/Increasing Efficiencies
Topic 1
Module CGT 13: Global Challenges and Harmonization
Topic 1
TRACK 2
Biosimilars and Novel mAbs
Details coming soon...
Panel Discussion 1: mAbs/Biosimilars: Functional Assessment/Analytics and Regulatory Inspection
Panel Discussion 2: AI and Biologics: From Bench to Clinical Trials
Panel Members: Coming Soon
Moderator: Coming soon
Module MAB 1: Upstream and Clone Development
Topic 1
Topic 2
Topic 3
Module MAB 2:New Tools and Product Development
Topic 1
Topic 2
Topic 3
Module MAB 3:BioAnalytics: New waves
Topic 1
Topic 2
Topic 3
Module MAB 4: Machine Leaning: How it works- New Approaches
Topic 1: Next Generation of Biologics
Topic 2
Topic 3
Module MAB 5: Antibody Design
Topic 1
Topic 2
Topic 3
Module MAB 6: AI- Endless opportunites
Topic 1: Antibody Design
Topic 2:
Topic 3
Module MAB 7: Manufacturing- What is next?
Topic 1: Batch- Fedbatch- Perfusion-…
Topic 2
Topic 3
Module MAB 8: BioAnalytics: New waves
Topic 1:
Topic 2
Topic 3
Module MAB 9: Clinical Development and CMC
Topic 1:
Topic 2
Topic 3
Module MAB 10: New Technologies
Topic 1:
Topic 2
Topic 3
Module MAB 11: Bio-Manufacturing/Automation/Digital Tools
Topic 1:
Topic 2
Topic 3
Module MAB12: Innovation and Global Challenges. Harmonization
Topic 1:
Topic 2
Topic 3
Some of the topics/ titles of talks that would be discussed….
Recent Advances in Process Development and Next Generation Manufacturing for Accelerated and Affordable Biosimilar Development
Successful Commercialization of Cell Therapy products in India
Overview of upstream process development for Biosimilars
Successful Cell Therapy Program: challenges associated with drug manufacturing and process and product characterization
Manufacturing of AAV and lentiviral vectors using HEK293 cells
Challenges in process development of CAR T cell therapy
Induced Pluripotent Stem Cells in Regenerative Medicine
NK and Gamma Delta T based Allogenic Cell Therapy
Decoding the future of Healthcare; A comprehensive survey of cell therapy outcomes
Product development: commercialization and market
Regulatory Inspection – Challenges and Opportunities for Biosimilar Products
Regenerative medicine drug development in India: Challenges and Opportunities
Novel Biologics Development- A case study
Strategizing the challenges during clone development
Current challenges of development and cGMP manufacturing of Cell and Gene Therapy products
Induced Pluripotent Stem Cells (iPSC) In Disease Modelling and Drug Discovery
Panel Discussion: Biosimilars: Recent Advances in Cell Engineering and Upstream Processes for Accelerated, high quality and Affordable MAb development
Moderator
Panel Discussion: Cell and Gene Therapy- Progress, Challenges, and future outlook
Moderator
Bioassay: Advancement in functional assessment of biologics and regulatory requirements
Beyond the Blueprint: AI-Powered Protein Engineering for a Brighter Future
Scalable & Efficient Production of Lentiviral vectors
Collaboration of IP and Biosimilar R&D for Early Market Access
Bringing best practices to India in Design of Biopharmaceutical Facilities
Translating Cell and Gene Therapies- From Concept to Commercialization
Agenda from Past Conferences